a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases.
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MXJVX | 8.82 | -0.01 | -0.11% |
Empower International Value Instl | |||
VTISX | 136.56 | -0.65 | -0.47% |
Vanguard Total Intl Stock Idx Instl Sel | |||
JIERX | 19.34 | -0.18 | -0.92% |
JPMorgan International Equity R5 | |||
TBLRX | 13.36 | -0.13 | -0.96% |
Transamerica Balanced II R | |||
GCLLX | 16.51 | -0.24 | -1.43% |
Goldman Sachs Enh Core EqFund-ClassC |
A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.
Ticker / NAME | Correlation To IMVT | 1D Price Change % | ||
---|---|---|---|---|
IMVT | 100% | -5.06% | ||
ROIV - IMVT | 58% Loosely correlated | -3.78% | ||
BRNS - IMVT | 48% Loosely correlated | -29.70% | ||
RVMD - IMVT | 42% Loosely correlated | -3.90% | ||
SNDX - IMVT | 40% Loosely correlated | -5.72% | ||
KYMR - IMVT | 38% Loosely correlated | -8.67% | ||
More |